Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Oxford North UK innovation district officially opened

October 16, 2025 Research and Development Oxford North, University of Oxford, innovation district

Oxford North, a new innovation district in Oxford, UK, with planning permission for around one million sq ft of newly …
News

Symeres appoints Gabriella Gentile as chief operating officer

October 13, 2025 Research and Development Symeres

Symeres, a mid-sized contract research, development and manufacturing organisation (CRDMO), has appointed Gabriella Gentile as its chief operating officer. Operating …
Appointment

Uterine fibroids and the cost of silence

October 9, 2025 Medical Communications, Research and Development Reproductive health, gynaecological conditions, menstruation, uterine fibroids

By Tina Backhouse Stigma and shame Every month, most women on the planet have a period. It’s completely natural – …
Feature

Recipharm designates Germany site as Centre of Excellence

October 9, 2025 Research and Development CDMO, Cuxhaven, Recipharm, biologics

The multi-product facility recently underwent significant renovations
News

Esaote presents new MRI system to support brain glioma surgeries

October 7, 2025 Research and Development Esaote, MRI, medical imaging, neurology

Gliomas are among the most common primary malignant brain tumours
News
drug-trials

Bio-Rad signs exclusive European distribution deal with Gencurix for oncology testing kits

October 6, 2025 Research and Development Bio-Rad, Diagnostics and Testing, Gencurix, oncology

The agreement expands access to oncology testing kits across Europe
News

The Pharma Files: With Colin Williams from Astellas Pharma

October 5, 2025 Medical Communications, Research and Development Astellas Pharma, Corporate, The Pharma Files, pm society

Pharmafile chats with Colin Williams, Head of Marketing Excellence, Global Capabilities, Learning & Development at Astellas Pharma about the best …
Feature

Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness

October 3, 2025 Medical Communications, Research and Development Dermatology, Immunology, acute urticaria, chronic spontaneous urticaria, dermatology, immunology

The current forms of immunotherapy, how T cell therapy works and what the future holds
Feature

Micrima announces upcoming launch of new UK breast cancer assessment

October 3, 2025 Research and Development Micrima, breast cancer, oncology

Breast cancer remains one of the leading health threats to women over 35 in the UK Micrima, a healthcare technology …
News
partnership

Nanoform partners with A&LS Pharma

October 2, 2025 Research and Development A&LS Pharma, Nanoform

Distribution agreement will make Nanoform’s products available in South Korea Nanoform Finland has entered into a distribution agreement with Ageing …
News

Unlocking nature’s pharmacy: how tea leaves and marine organisms could help transform breast cancer treatment

October 2, 2025 Research and Development King Abdullah University of Science and Technology, Oncology, natural products chemistry, triple-negative breast cancer

Looking beyond synthetic chemistry to unlock powerful, naturally derived medicines Each year, World Breast Cancer Awareness Month serves as a …
Feature

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria

September 26, 2025 Research and Development Dupixent, Regeneron, Sanofi, urticaria

Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …
News
hsm_mobile_clinical_trial_istock-872676342

CSL Behring’s angioedema treatments receives NICE recommendation

September 26, 2025 Regulatory Affairs, Research and Development Andembry, CSL Behring, hereditary angioedema

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending CSL Behring’s ANDEMBRY (garadacimab) for …
News
drug-trials

Gilead Foundation awards $6.5m in grants to support STEM education

September 26, 2025 Research and Development Funding and Investment, Gilead Sciences, stem

Gilead Sciences has committed over $6.5m in grant funding towards improving science, technology, engineering and maths (STEM) education, the company …
News

Lilly opens fourth US Gateway Labs site

September 26, 2025 Research and Development Eli Lilly, Local Investment, biotech, life sciences

Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, expanding its network of shared …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025